MEI Pharma Reports Second Quarter Fiscal Year 2017 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
MEI Pharma (MEIP) Reports Q2 EPS of $0.32
February 8, 2017 8:38 AM ESTMEI Pharma (NASDAQ: MEIP) reported Q2 EPS of $0.32, versus ($0.15) reported last year. Revenue for the quarter came in at $17.1 million, versus $0 reported last year.
For earnings history and earnings-related data on MEI Pharma (MEIP) click here.
... More